Introduction
Restoration from peripheral nerve injury requires both neuronal cell survival and axonal regeneration across the site of injury and along the distal nerve stump as well as functional reconnection with the appropriate targets. It is no doubt that the concerted interplay of regenerating axons, non-neuronal cells (e.g. Schwann cells and macrophages), neurotrophic factors and cytokines, cell adhesion molecules, and extracellular matrix components is essential for successful nerve regeneration (Zochodne, 2008) . A plenty of molecules have been implicated in the regenerative response to nerve injury (Terenghi, 1999; Yasuda et al., 2003) and the therapeutic approaches using the delivery systems for the target genes have been receiving increasing attention (Mason et al., 2011) ; however, the signals that prompt neurons to extend processes in peripheral nerves after injury are not fully understood.
We have established three-dimensional collagen gel culture system of ganglion explants, in which adult peripheral ganglia (mainly dorsal root ganglia (DRG)) with nerve fibers are embedded in collagen gel and the number and length of regenerating neurites from nervetransected terminals are measured under a phase-contrast microscope ( Fig.1, right; reproduced from Sango et al., 2006) . Since the cell-cell interactions are maintained in the explanted ganglia, it is fair to state that the explant culture system mimics nerve regeneration in vivo better than the dissociated cell culture system (Fig.1, left) . By employing the explant models, we showed that various kinds of neurotrophic factors (Horie et al., 1991a; Akahori et al., 1997) , cytokines (Horie et al., 1997; Shuto et al., 2001 ), co-cultured tissues (Horie et al., 1991b; Saito et al., 2002) and experimental diabetes (Saito et al., 1999; Sango et al., 2002) enhanced neurite regeneration. Fig. 1 . Schematic representation of the methods for dissociated cell culture and explant culture of peripheral ganglia. In the former, each of the ganglion neurons is mechanically and enzymatically isolated, and seeded onto culture dishes precoated with extracellular substrate(s). In the latter, peripheral ganglia with nerve fibers are embedded in collagen gel. The number and length of regenerating neurites from nerve-transected terminals are measured under a phase-contrast microscope (Reproduced from Sango et al., Current Diabetes Reviews, 2006, Vol.2, No.2, pp.169-183 , with permission from Bentham Science Publishers Ltd.).
Furthermore, we searched for novel axonal regeneration-promoting factors from the culture supernatants of COS1 cells (a cell line derived from the kidneys), and purified the protein with molecular weight of around 14 kDa. The analysis of the internal amino acid sequences of the active protein indicated that it was identical to galectin-1 (GAL-1) . GAL-1 is a member of the galectins, a family of -galactoside binding animal lectin (Barondes et al., 1994) and has been shown to play roles in a wide variety of biological functions such as cell growth and differentiation, apoptosis, cell adhesion, tumor spreading, and inflammatory response (Camby et al., 2006; Rabinovich et al., 2007) . Most of the studies on the biological activities of GAL-1 were performed under reducing conditions, and the effects of GAL-1 were inhibited by lactose. However, the 14 kDa protein secreted from COS1 cells exists as an oxidized form of GAL-1 (GAL-1/Ox), containing three intramolecular disulfide bonds (Cys 2 -Cys 130 , Cys 16 -Cys 88 , and Cys 42 -Cys 60 ) as shown in Fig. 2. (reproduced from .
In contrast to the concept that GAL-1 is biologically active only in the reduced form, we introduced GAL-1/Ox as a novel factor enhancing axonal regeneration in peripheral nerves (Inagaki et al., 2000; Horie et al., 1999 Horie et al., , 2004 . The potent activity of recombinant human GAL-1/Ox on axonal regeneration has been confirmed by several in vivo experiments Fukaya et al., 2003; . Fig. 2 . Bubble map of reduced and oxidized GAL-1. GAL-1 having -galactoside-binding activity exists in a reduced form, whereas oxidized GAL-1 contains three intramolecular disulfide bonds (Reproduced from Kadoya & Horie, Current Drug Targets, 2005, Vol.6, No.4, pp. 375-383 , with permission from Bentham Science Publishers Ltd.)
The growing evidence suggests that both reduced and oxidized forms of GAL-1 are involved in the repair process after nerve injury (Camby et al., 2006) , but there is a marked difference in the structural and functional properties between the two forms; GAL-1 in the reduced form acts on nervous tissue as a lectin (Sasaki et al., 2004; Plachta et al., 2007) , whereas GAL-1/Ox lacks lectin activity and acts as a cytokine-like molecule Inagaki et al., 2000; . In this chapter, we further characterize GAL-1 as a multi-functional molecule in the peripheral nervous system, focusing on its distribution, regulation of synthesis, extracellular release and oxidation, and possible action mechanisms for neuroprotection and axonal regeneration after injury.
Localization of GAL-1 in the peripheral nervous system
GAL-1 is encoded by the LGALS1 gene located on the human chromosome 22q13.1. The 0.6 kb transcript results from the splicing of four exons and encodes for a protein of 135 amino acids. It exists as a monomer as well as a non-covalent homodimer with a subunit molecular weight of 14.5 kDa (Barondes et al., 1994; Sango et al., 2004) . GAL-1 is highly expressed in peripheral nervous tissues of adult rodents, with immunoreactivity localized to cell bodies of sensory and motoneurons, axons and Schwann cells (Fukaya et al., 2003; Akazawa et al., 2004) . GAL-1 mRNA persists in DRG neurons at later developmental stages and is maintained in adult DRG neurons. Using in situ hybridization histochemistry, GAL-1 mRNA has been detected in nearly all neurons of the DRG. In general, the staining intensity in smaller diameter (<30 m) neurons www.intechopen.com Basic Principles of Peripheral Nerve Disorders 34 was higher than that in larger diameter neurons . The small DRG neurons are reported to have small myelinated (A) and unmyelinated (C) fibers, which can play an essential role in thermoreception and nociception; whereas the large neurons have large myelinated (A) fibers and are known to be mostly sensitive mechenoreceptors (Salt & Hill, 1983) . Therefore, predominant expression of GAL-1 mRNA/protein in subpopulations of small diameter neurons (Regan et al., 1986 , Hynes et al., 1990 , Imbe et al., 2003 , McGraw et al., 2005a suggests that this molecule is involved in the transmission of nociceptive and thermoceptive information. In fact, mice lacking GAL-1 showed reduced sensitivity to noxious thermal stimuli (McGraw et al., 2005b) .
Predominant expression of GAL-1 in small IB4-binding DRG neurons in vivo
Adult DRG neurons can be broadly divided into three principal subgroups by their soma size and characteristic markers ( 1. large neurons; immunoreactive for 200 kD neurofilaments (NF200), 2. small peptidergic neurons; immunoreactive for calcitonin gene-related peptide (CGRP) and high-affinity NGF receptor (trkA), and 3. small non-peptidergic neurons; immunoreactive for GDNF receptors (Ret, GFR) and binding to isolectin B4 (IB4). Both small peptidergic and non-peptidergic neurons are responsible for the transmission of nociception and thermoreception, and whether these two groups of neurons have distinct functions has been the subject of controversy (McMahon & Bennett, 2000; Ernsberger, 2009) . Fig. 4 . Predominant expression of GAL-1 in small non-peptidergic neurons of adult rat DRG. Immunofluorescence micrographs of adult rat DRG sections, stained with antibodies to GAL-1 (red) and CGRP, IB4, or NF200 (green). The merged pictures are on the right. Almost all GAL-1 intensely labeled neurons are IB4-binding neurons, and distinguished from CGRP intensely labeled neurons and NF200 intensely labeled neurons.
Our immunohistochemical analysis revealed intense immunoreactivity for GAL-1 in a subset of small diameter neurons in the sections of adult rat lumbar DRG (Fig.4, left) . The ratio of GAL-1-immunoreactive (IR) neurons was 31.6±5.4 (mean±SD from nine sections, 1717 neurons from three animals). By double immunofluorescent staining, 96.5±1.3 of the GAL-1-IR neurons were IB4-binding, whereas 3.7±1.2% and 0% were CGRP-IR and NF200-IR, respectively (Fig.4 , center and right). These findings agree with the previous study by Imbe et al. (2003) ; they performed immunohistochemistry and in situ hybridization using two pairs of consecutive sections of lumbar DRG, and observed that 93.9% and 6.8% of the intensely GAL-1-IR neurons displayed mRNA for c-RET and trkA, respectively. On the other hand, the double immunofluorescent staining with the sections of cervical DRG (McGraw et al., 2005a) showed that 33% and 28% of the GAL-1-IR neurons were IB4-binding and CGRP-IR. Such differences may arise from variations in the distribution of GAL-1 at different spinal levels and/or different evaluation of the intensity for GAL-1-IR among the investigators. The finding that mice lacking GAL-1 showed reduced proportion of IB4-binding DRG neurons (McGraw et al., 2005b) indicates the involvement of GAL-1 in the proper phenotypic differentiation of the non-peptidergic DRG neurons during development.
GDNF upregulates protein expression of GAL-1 in cultured DRG cells
Our immunohistochemical analyses revealed that almost all the GAL-1 intensely stained DRG neurons were IB4-binding small non-peptidergic neurons (Figs.3&4) . Since NGF and GDNF are likely to exert their major effects on small peptidergic and non-peptidergic neurons, respectively (Molliver et al., 1997) , it seems plausible that GDNF regulates synthesis and/or distribution of GAL-1 in non-peptidergic DRG neurons. Following peripheral axotomy, GAL-1 expression was downregulated in small DRG neurons but was upregulated in NF200-IR large neurons (Imbe et al., 2003; McGraw et al., 2005a) . These findings imply that retrogradely transported NGF and/or GDNF play a role in the dominant expression of GAL-1 in small DRG neurons (Lindsay & Harmar, 1989; Bennett et al., 1998) .
By employing the dissociated cell culture model (Fig.1, left) , we examined the effects of recombinant NGF and GDNF on neurite outgrowth and GAL-1 expression in adult rat DRG. As shown in previous studies (Lindsay, 1988; Gavazzi et al., 1999; Sango et al., 2008) , both NGF and GDNF promoted neurite outgrowth from small DRG neurons (Fig.5) . Fig. 5 . Adult rat DRG neurons after 2 days in culture were immunostained with anti-III tubulin. An application of NGF or GDNF to culture medium (50 ng/ml) enhanced neurite outgrowth, and their effects were small neuron-dominant.
Immunocytochemical analysis showed intense GAL-1-IR in almost all neurons from a very early stage (3 h) to an end of the observation period (> 7 days) in culture in the absence of NGF or GDNF (Fig.6 ). This finding is in contrast to the predominant expression of GAL-1 in small non-peptidergic neurons in vivo. Enzymatic and mechanical treatments for the dissociation of DRG cells, together with disruption of interactions between neurons and non-neuronal cells are detrimental to neurons. Therefore, GAL-1 expressed in cultured neurons may function as a stress marker protein (Iwamoto et al., 2010) and/or a cytoprotective molecule (Lekishvili et al., 2006) during in vivo-in vitro replacement. Western blot analysis. The neuron-enriched culture of DRG 12 h after seeding was incubated with serum-free medium containing 50 ng/ml of NGF or GDNF for 36 h.
The abundant expression of GAL-1 in cultured DRG neurons under the basal conditions (Ham's H12 /B27 supplement in the absence of NGF or GDNF) made it difficult to evaluate the effects of NGF or GDNF on the GAL-1-IR by immunocytochemistry. Then we prepared the neuron-enriched DRG culture (>5  10 3 cells/cm 2 at seeding) for Western blot analysis as previously described (Sango et al., 2007) . The blot showed that GDNF, but not NGF, upregulated protein expression of GAL-1 (Fig.7) . This finding suggests that GAL-1 is one of the downstream target molecules of GDNF in cultured DRG neurons. Our current study is aimed at elucidating the signaling molecules and pathways involved in the GDNF-induced neurite outgrowth and upregulation of GAL-1 (Sango et al., in preparation).
Externalization of GAL-1 from neurons and Schwann cells
Despite lacking a signal leading peptide, GAL-1 is subject to externalization via non-classical pathway from various kinds of cells (Cooper & Barondes, 1990; Avellana-Adalid et al., 1994; Hughes, 1999) . Our immunocytochemical and Western blot analyses showed the externalization of GAL-1 from primary cultured adult rat DRG neurons and Schwann cells, and immortalized adult mouse Schwann cells IMS32 (Watabe et al., 1995; Sango et al., 2004 ).
I n a d d i t i o n t o t h e s e c e l l s , w e h a v e r e c e ntly established spontaneously immortalized
Schwann cell lines from long-term cultures of adult Fischer 344 rat DRG and peripheral nerves. One of these cell lines, designated IFRS1, showed distinct Schwann cell phenotypes, such as spindle-shaped morphology under phase-contrast microscopy ( Fig.8A) , intense immunoreactivity for Schwann cell markers (e.g. S100 and p75 low affinity neurotrophin receptor(p75 NTR )), mRNA expression for neurotrophic factors (NGF, GDNF, CNTF), cell adhesion molecules (L1, NCAM, N-cadherin), transcription factors (Sox10, Oct6, Krox20) and myelin proteins (P0, PMP22, MAG) (Sango et al., 2011) . Moreover, IFRS1 cells are capable of myelinating neurites in coculture with adult rat DRG neurons (Sango et al., 2011) and NGFprimed PC12 cells (Sango et al., submitted) . We observed the intense immunoreactivity for GAL-1 in the cell bodies and processes of IFRS1 cells (Fig.8B) . Further, Western blot analysis revealed the intense immunoreactivity for GAL-1 in both IFRS1 cells and culture medium (supernatant) (Fig.8C ). These findings suggest that IFRS1 cells synthesize and secrete GAL-1, in a similar manner to DRG neurons and IMS32 cells .
Following externalization, some of the galectin molecules are suggested to associate with surface or extracellular matrix glycoconjugates where lectin activity is stabilized, whereas the others free from glycoconjugate ligands are rapidly oxidized in the non-reducing extracellular environment (Tracey et al., 1992) . 
Biological roles of GAL-1 in the nervous tissue after injury
As described above, GAL-1 exists in both an oxidized and reduced state and only shows the lectin activity in its reduced state. Several studies have been conducted on the bioactivity of the reduced form of GAL-1 on the nervous tissue after injury, whereas we have been focusing on the axonal regeneration-promoting activity of GAL-1/Ox.
GAL-1 in the reduced form
The bioactivity of recombinant reduced GAL-1 was examined in vitro. When used as a coating substrate, it promoted adhesion, aggregation and neurite fasciculation of newborn rat DRG neurons (Outenreath & Jones, 1992) and olfactory neurons (Mahanthappa et al., 1994; Puche et al., 1996) . In contrast, however, we saw no significant effects of GAL-1 on adhesion or neurite outgrowth of adult rat DRG neurons (Sango et al., unpublished data) . When applied to culture medium, it induced differentiation of primary cultured rat cerebellar astrocytes and production of brain-derived neurotrophic factor (BDNF) (Sasaki et al., 2004; Endo, 2005) . Since these changes were inhibited by lactose, the lectin activity of GAL-1 appears to be essential for the induction of astrocyte differentiation. These findings suggest that GAL-1 in the reduced form is involved in the neuroprotective function via acting on astrocytes after brain injury.
Using embryonic stem cell-derived neurons engineered with a p75 NTR cDNA, Plachta et al. (2007) identified GAL-1 in the reduced form as an inducible factor for the degeneration of neuronal processes. They also showed the delayed elimination of peripheral nerve endings after sciatic nerve injury in GAL-1 deficient mice. These finding suggest that GAL-1 play a major role in the process of Wallerian degeneration and subsequent functional reinnervation after peripheral nerve injury.
GAL-1 in the oxidized form (GAL-1/Ox)
The bioactivity of recombinant GAL-1/Ox was initially evaluated by DRG explant culture models, as shown in Fig.1 . GAL-1/Ox did not show the lectin activity, but enhanced neurite outgrowth from transected nerve terminals of DRG explants in a dose-dependent manner (pg/ml range). We prepared a GAL-1 mutant CSGAL-1, in which all six cysteine residues were replaced by serine. CSGAL-1 did not promote neurite outgrowth, but showed lectin activity even under non-reducing conditions (Inagaki et al., 2000) . These findings indicate that the axonal regeneration-promoting activity of GAL-1/Ox is unrelated to its lectin properties.
In stark contrast to the neurotrophic factors (e.g. NGF, GDNF, and CNTF), recombinant GAL-1/Ox does not directly work on isolated DRG neurons to promote neurite outgrowth Inagaki et al., 2000) . Application of fluorescence-conjugated GAL-1/Ox to DRG neurons, Schwann cells, and peritoneal macrophages, showed that only the surface of macrophages was clearly labeled . This finding suggests that macrophages are a target cell of GAL-1/Ox. Consistently, recombinant GAL-1/Ox induced tyrosine phosphorylation of proteins in macrophages. Furthermore, conditioned medium from GAL-1/Ox-stimulated macrophages enhanced neurite regeneration and Schwann cell migration from DRG explants greater than that from non-activated macrophages. These findings suggest that GAL-1/Ox binds to macrophages to activate their signal transduction pathways and secrete some neurotrophic molecules. Taking these findings together with those described above, we proposed a possible action mechanism of GAL-1/Ox for the promotion of axonal regeneration after injury (Fig.9) . First, cytosolic GAL-1 is released from growing axons and Schwann cells into the extracellular space upon axonal injury. Next, some of the molecules in the extracellular milieu is converted to the oxidized form (GAL-1/Ox). Finally, GAL-1/Ox stimulates macrophages to release some neurotrophic molecules, which in turn enhance neurite regeneration and Schwann cell migration. This hypothesis will be further strengthened by identification of specific receptors for GAL-1/Ox on the macrophages and neurotrophic molecules secreted from macrophages. A recent study by Echigo et al. (2010) showed that GAL-1/Ox acts on the macrophage cell line RAW264.7 to induce phosphorylation of extracellular signal-regulated protein kinase 1/2 (ERK1/2). This cell line can be a valuable tool for the elucidation of the precise mechanisms underlying the promotion of axonal regeneration by GAL-1/Ox. Fig. 9 . A possible action mechanism of GAL-1 for the promotion of axonal regeneration. Some of the GAL-1 molecule released from neurons and Schwann cells are converted to the oxidized form with intramolecular disulfide bonds, which lacks lectin activity but could promote axonal regeneration and Schwann cell migration via activating macrophages. Gaudet et al. (2009) precisely investigated a role for GAL-1 in the accumulation of macrophages following peripheral nerve injury. They observed that the axotomy-induced accumulation of macrophages in normal mouse sciatic nerve distal to ligation was inhibited by injection of anti-GAL-1 antibody. Consistently, mice lacking GAL-1 exhibited delayed and diminished macrophage accumulation by sciatic nerve injury. Further, injection of GAL-1/Ox into uninjured sciatic nerve enhanced the accumulation of macrophages in normal mice. These findings indicate the implication of GAL-1/Ox, as well as GAL-1 in the reduced from (Plachta et al., 2007) , in the prompt response of macrophages to nerve injury, which is essential for Wallerian degeneration.
Conclusion
Since we introduced GAL-1/Ox as a novel axonal regeneration-promoting factor after injury ), a considerable number of studies have been made on the biological properties of GAL-1 in the nervous system. GAL-1 is a multifunctional protein and plays different roles dependent on whether it is in the reduced or oxidized form. It is noteworthy that both reduced and oxidized forms of GAL-1 participate in the process of Wallerian degeneration (Plachta et al., 2007; Gaudet et al., 2009) , although the precise mechanisms underlying it remain unclear. The growing evidence from both in vivo and in vitro studies suggests that GAL-1/Ox may be useful as a novel therapeutic agent for functional restoration after peripheral nerve injury.
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